Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017
NEW YORK, Dec. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017
Clinical and patient benefits are driving the Hospital-based Point-of-Care product sector, which achieved growth of 7.5% in 2011
US$2.9 billionThe benefits are clear. Hospital-based POC diagnostics offer healthcare providers an opportunity to improve the quality of patient care while saving time and reducing costs. A faster diagnosis can mean a faster medical intervention, potentially avoiding the need to admit a patient into hospital and the costs incurred as a result, while also freeing up that hospital bed.
The integration of IT connectivity and data management features enables POC analysers to communicate with hospital IT systems and electronic patient records in order to increase efficiency, facilitate quality control and reduce the chance of user error.
The development of new technologies that enable DNA analysis and the identification of hospital-acquired infections such as MRSA at the point of care.
The patient experience is improved with shorter waiting times and hospital stays, and lower rates of hospital-acquired infections.
Automated calibration, processing and operation features eliminate the need for medical staff to add reagents or undertake manual handling steps as errors in these areas can impact patient safety and the accuracy of POC test results.
Challenges remain...
This new November 2012 report delivers a complete analysis
This new 182-page highly-detailed report Hospital-based Point-of-Care Diagnostics: Products, Players and Outlook to 2017 provides executives with a complete understanding of the issues which are shaping the market and how that will affect its commercial development. This is Volume 2 of a 4-Volume study of the whole POC IVD sector to be published late 2012/early 2013. See overleaf for more details and discounts.
Focus on...
The Competitive Environment
There are around 80 companies active in the hospital POC diagnostics market, although many are development-stage or have limited product portfolios. The market is currently dominated by Alere (previously Inverness Medical Innovations), Abbott, Radiometer, Roche and Siemens. Currently, Abbott, Radiometer, Roche and Siemens have strong positions in the markets for clinical chemistry and blood gas analysis; Abbott, Alere and Roche are leaders for POC cardiac marker testing; and Beckman Coulter, Quest Diagnostics, Horiba and Sysmex are key companies in POC haematology diagnostics.
Contents
EXECUTIVE SUMMARY...1
INTRODUCTION2
POC Testing in a Hospital Setting...2
CURRENT MARKET DYNAMICS ..4
Fig.1: POC Diagnostics in Relation to the IVD Market, 2011.4
Fig.2: Percentage of POC Diagnostics Market by Product, 2011..5
Regional Perspective ..5
Fig.3: Professional POC Diagnostics Market by Region, 2011..6
Regulatory and Reimbursement Environment6
CLIA Waiver.6
Hospital POC Testing Market..7
Hospital POC Testing Market by Product Type, 2007-2011 (US$ million)8
Fig.4: Hospital POC Testing Market by Product Type, 2011..8
COMPETITIVE LANDSCAPE.9
Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)...9
Market Leaders by Hospital POC Testing Product Type...9
Merger and Acquisition Activity ..10
Key Hospital POC Diagnostics Mergers and Acquisitions, 2008-2012...10
GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES..12
Clinical Utility and Accuracy.12
Connectivity...12
POC Diagnostics as a Disruptive Technology..13
POC Diagnostics and the Economy..14
Future Technology: Next-Generation POC Diagnostic Products..14
Lab-on-a-Chip Devices and Microfluidics...14
Detecting Hospital-Acquired Infections.15
Summary: Market Drivers, Restraints and Opportunities16
FUTURE MARKET PROSPECTS..17
Hospital POC Testing Market by Product Type, 2011-2017E (US$ million).17
Hospital POC Testing Market by Product Growth, 2008-2017E (%)..18
Fig.5: Predicted Hospital POC Testing Market by Product, 201718
HOSPITAL POC TESTING PRODUCTS AND TECHNOLOGIES.19
MULTI-FUNCTIONAL CLINICAL CHEMISTRY ANALYSERS 19
Abaxis' Piccolo xpress ...19
Abbott's i-STAT System .20
Alfa Wassermann's ACE Clinical Chemistry Systems ..21
Arkray's SpotChem Systems 22
SpotChem Test Strips..22
Audit Diagnostics' Liqui-Stat and DryLab Systems22
DiaSys Diagnostic Systems' InnovaStar ..23
Horiba's ABX Pentra Clinical Chemistry Analysers .23
Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System.23
Radiometer's AQT90 FLEX Immunoassay Analyser24
Randox Laboratories' Evidence Multistat...24
Samsung's LABGEO Clinical Chemistry Analysers..25
Tosoh Bioscience's AIA Immunoassay Analysers25
POC BLOOD GAS/ELECTROLYTE ANALYSERS27
Fig.6: POC Clinical Chemistry Market, 2007-2017E (US$ million)..27
Arkray's SpotChem EL Electrolyte Analyser28
Epocal's epoc Blood Analysis System ..28
Instrumentation Laboratory's GEM Premier Products .29
tBili Assay..29
November 2012 iii
Hospital Point-of-Care Diagnosticsiv
Table of Contents Hospital Point-of-Care Diagnostics
GEMweb Plus .. 29
ITC's IRMA TRUpoint Blood Analysis System...30
ITC's AVOXimeter Products...30
Nova Biomedical's Critical Care Analysers ..30
pHOx Ultra Blood Gas Analyser... 30
Stat Profile pHOx 31
Stat Profile Critical Care Xpress 31
Nova Electrolyte/Chemistry Analysers...31
Hand-Held Analysers..32
OPTI Medical Systems' Products..32
Radiometer's Blood Gas Analysers ..32
1st automatic32
ABL90 FLEX ..33
ABL800 FLEX.33
Avoid Errors App 34
Roche's cobas Blood Gas Analysers .34
Siemens' Blood Gas Analyser Range ...35
RAPIDPoint Analysers.35
RAPIDLab Analysers... 36
RAPIDChem 744/754 Electrolyte and Lithium Testing ... 36
RAPIDComm Data Management and Connectivity Solution 36
Via Medical's Products ..37
POC HAEMATOLOGY AND HAEMOSTASIS PRODUCTS... 38
Fig.7: Global POC Haematotolgy Market, 2007-2017E (US$ million)...38
Haematology Analysers39
Beckman Coulter's COULTER AC•T Series ...39
Horiba's Haematology Analysers.39
Samsung's LABGEO HC10 ..41
Sysmex' pocH-100i Haematology Analyser ...41
POC Haemoglobin Systems ..41
POC Analyser Accuracy...42
Available Products 43
Arkray's PocketChem BA Blood Ammonia Meters 48
Surgical Coagulation and Haemostasis Management.. 48
Akers Biosciences' PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays 49
Haemonetics' TEG Thrombelastograph Hemostasis Analyzer.. 49
Medtronic's HMS PLUS Haemostasis Management System.. 50
Pentapharm's ROTEM delta.. 50
Sienco's Sonoclot Coagulation & Platelet Function Analyzers.. 50
Platelet Function Assessment..51
Clinical Guidelines...51
Accumetrics' VerifyNow System...52
Helena Laboratories' Plateletworks System..53
POC CARDIAC MARKER TESTING54
PROTECT Study55
VISION Study... 56
POC Testing56
Gaining Clinical Evidence...57
Market Dynamics... 58
Fig.6: Global POC Cardiac Marker Testing Market, 2007-2017E (US$ million) .58
POC Testing Products.59
Currently-Available Cardiac Marker POC Tests.59
POC URINALYSIS 69
Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million)...69
Key Urine Analysis Test Strips...70November 2012 v
Hospital Point-of-Care Diagnostics Table of Contents
Product Highlights 70
77 Elektronika's DocUReader 2 and DocuReader 2 Pro...70
ACON Laboratories' Mission Products.70
Arkray's Products71
Roche's Products.71
Siemens' Products.. 72
OTHER POC PRODUCTS 74
Labour and Delivery Testing 74
Alere's Triage PLGF Assay...74
Amnisure International's AmniSure ROM Test...75
Medix Biochemica's Actim PROM and Actim Partus.75
Liver Function Testing...76
Exalenz Bioscience's BreathID System76
Infopia's Pioneer POCT Liver Test Sensor76
Alere's Triage NGAL Test ...77
bioMérieux' VIDAS B•R•A•H•M•S PCT. Test...77
Magellan Biosciences' LeadCare II System..78
Medix Biochemica's Actim Pancreatitis ..78
Products in Development.78
Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check 78
EMERGING TECHNOLOGIES.80
Applied Nanodetectors' Sensor Array Platform.80
Atonomics' Atolyzer..80
Ativa Medical's POC System..81
Bio-AMD's MPR..81
Biosensia's RapiPlex .82
Fiomi Diagnostics (Trinity Biotech) Forecast Technology..82
MagnaBioSciences' MICT On-Site System...83
Micronics' ABORhCard and ABO-XM Card...83
Molecular Vision .. 84
MycroLab... 84
OPKO Health's OPKO Diagnostics Platform 85
pes diagnosesysteme' respons IQ86
Philips' Minicare 86
Radisens Diagnostics' POC Platform ...87
T2 Biosystems' T2Dx System88
T2Hemostasis Assay .. 89
Tyrian Diagnostics' DiagnostIQ ...89
Hospital-Acquired Infection Testing ...90
Cepheid's GeneXpert..91
Atlas Genetics' POC System...92
BioFire Diagnostics' FilmArray System92
Immunexpress' SeptiCyte Technology ...93
Rheonix' EncompassMDx Platform 94
HOSPITAL POC TESTING MANUFACTURERS 95
COMPANY DIRECTORY. 95
SELECTED COMPANY PROFILES100
Abaxis .. 100
Piccolo xpress 100
Financial Performance 101
Abaxis Operating Results, 2007-2012 (US$ million)...101
Abbott ..102
Recent Key Events...102
i-STAT Point of Care Products. 102vi
Table of Contents Hospital Point-of-Care Diagnostics
Alliance with Abaxis. 104
Financial Performance 104
Abbott Point of Care Sales, 2010-2011 (US$ million).104
Fig.10: Percentage of Abbott Point of Care Revenue by Region, 2011104
Accumetrics .105
Recent Key Events...105
Fig.11: Accumetrics Revenue, 2005-2011 (US$ thousand).105
VerifyNow System 106
Distribution Agreements 107
Akers Biosciences 108
Recent Key Events...108
Current Products.. 109
Research and Development... 109
Current Alliances and Distribution Agreements.110
Financial Performance .111
Akers Biosciences Operating Results, 2007-2011 (US$ thousands).111
Fig.12: Percentage of Akers' Revenue by Product Type, 2011..112
Alere..113
Recent Key Events113
POC Cardiology Diagnostic Products114
Women's Health 116
RALS-Plus POC IT Solution...116
POC Mergers & Acquisitions117
Current Alliances...119
Financial Performance 120
Alere - Operating Results, 2007-2011 (US$ million)...121
Fig.13: Percentage of Alere's Revenue by Segment, 2011...121
Fig.14: Percentage of Alere's Revenue by Region, 2011..121
Alere Professional Diagnostics Operating Results, 2007-2011 (US$ million).122
Professional Diagnostics Net Sales & Services Revenue, 2007-2011 (US$ million) 122
Fig.15: Alere Professional Diagnostics Net Sales & Services Revenue by Product, 2011.122
Alere Consumer Diagnostics Operating Results, 2007-2011 (US$ million).122
Arkray ...124
Recent Key Events...124
POC Testing Products ..124
Current Alliances.. 126
bioMérieux...127
bioNexia POC Tests...127
VIDAS Tests.127
Current Alliances.. 128
Financial Performance 129
bioMérieux - Operating Results, 2007-2011 (EUR million).129
Fig.16: Percentage of bioMérieux' Revenue by Product Type, 2011130
Fig.17: Percentage of bioMérieux's Revenue by Region, 2011130
Horiba Medical.131
Recent Key Events...132
Haematology Analysers...132
ABX Pentra 400 Clinical Chemistry Analyser... 134
Pentra C200 Clinical Chemistry Analyser. 134
Financial Performance 134
Fig.18: Percentage of Horiba's Revenue by Division, 2011..134
Horiba Medical - Operating Results, 2007-2011 (¥ million)...135
Fig.19: Percentage of Horiba Medical's Revenue by Region, 2011..135
Fig.20: Percentage of Horiba Medical's Revenue by Product Type, 2011...135November 2012
Hospital Point-of-Care Diagnostics Table of Contents
Instrumentation Laboratory..137
Recent Key Events...137
POC Critical Care Diagnostics..137
Purchasing Contracts... 138
International Technidyne Corporation .139
Products. 139
Current Alliances.. 140
Financial Performance 140
International Technidyne Operating Results, 2004-2009 (US$ million)141
Fig.21: International Technidyne Revenue, 2000-2010 (US$ million)141
Nova Biomedical..142
Critical Care Analysers. 142
Hand-Held Analysers... 143
Quest Diagnostics144
HemoCue Products.. 144
Litigation with EKF Diagnostics. 146
Financial Performance 146
Quest Diagnostics - Operating Results, 2007-2011 (US$ million)..147
Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million)147
Fig.22: Quest Diagnostics - Revenue by Division, 2011..147
Radiometer (Danaher) 149
Recent Key Events...149
AQT90 FLEX Immunoassay Analyser 150
Blood Gas Analysers 150
AQURE POC Management System 152
RADIANCE IT system 152
Current Alliances.. 152
Financial Performance 153
Fig.23: Radiometer - Revenue by Region, 2010.153
Response Biomedical..154
Recent Key Events...154
RAMP System 155
Current Alliances.. 156
Financial Performance 157
Response Biomedical - Operating Results, 2007-2011 (C$ thousands)..157
Response Biomedical - Product Sales by Category, 2009-2011 (C$ thousands)158
Fig.24: Response Biomedical - Product Sales by Category, 2011158
Response Biomedical - Revenue by Region, 2009-2011 (C$ thousands)...158
Fig.25: Response Biomedical - Revenue by Region, 2011...159
Roche Diagnostics ...160
Recent Key Events...160
Cardiac Testing Products.161
cobas Blood Gas Analysers..161
Urinalysis 162
cobas POC IT Solution.. 162
Current Alliances and Contracts 163
Financial Performance 163
Roche Diagnostics Operating Results, 2010-2011 (SFr million)..164
Fig.26: Roche Diagnostics - Revenue by Product Line, 2011..164
Fig.27: Roche Professional Diagnostics - Revenue by Region, 2011...164
Siemens Healthcare Diagnostics ...166
Recent Key Events...166
Blood Gas Analyser Range.. 166
Urinalysis 168
Cardiology - Stratus CS Analyzer... 169Table of Contents
Hospital Point-of-Care Diagnostics
RAPIDComm Data Management and Connectivity Solution...170
Current Alliances and Supply Contracts170
Financial Performance .170
APPENDICES ...172
APPENDIX 1 - LIST OF ABBREVIATIONS... 172
APPENDIX 2 - REPORT METHODOLOGY.. 173
To order this report:
In_Vitro_Diagnostic Industry: Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article